BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

NCT02090543 · clinicaltrials.gov ↗

COMPLETED

Status

647

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Phenprocoumon (Marcumar)
DRUG: Rivaroxaban (Xarelto, BAY-59 7939)

Sponsor

Bayer

Collaborators

[object Object]